This in silico outcome was rather interesting, considering that several studies showed that A3AR, together with other purinergic receptors, may have a role in lung inflammation and that targeting these receptors for pulmonary diseases might be of therapeutic interest [53,54,55]. The gene discussed is ADORA3; the disease is lung disorder.